相关实验视频
Updated: Jan 11, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
TMBclaw:瘤克隆意识图表学习改善了跨异构队列的免疫治疗反应预测
Yixuan Wang1, Tianyi Zhu2, Xiaofeng Song1
1Department of Biomedical Engineering, College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, 29 Jiangjun Avenue, Jiangning, Nanjing 211106, Jiangsu, China.
Briefings in bioinformatics
|November 8, 2025
概括
一种名为TMBclaw的新方法通过分析瘤突变负担和克隆异质性来改善免疫治疗反应的预测. 这种方法增强了患者分层,以获得更好的癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要,但有效的患者分层需要更好的生物标志物.
- 目前的瘤突变负担 (TMB) 指标由于瘤克隆异质性,无法完全捕捉免疫性新抗原呈现.
- 研究中的有限队列大小阻碍了预后模型的概括性.
研究的目的:
- 开发一个先进的框架,TMBclaw,通过整合克隆动态来预测免疫治疗反应.
- 通过解决瘤异质性来改善瘤学中的预后准确性和患者分层.
- 为了实现跨队列知识转移和探索克隆关系,以提高免疫疗法预测.
主要方法:
- 提议的TMBclaw (基于瘤突变负担的克隆注意力与拉普拉斯适应权重),一个图形规范化的多任务学习框架.
- 集成的群组结构的队列,用于统一的分析和跨队列的知识转移.
- 在NSCLC,黑色素瘤和鼻癌的四个队列 (238名患者) 和外部验证队列 (1433名患者) 上验证了模型.
主要成果:
- 在预后准确性和风险分层方面,TMBclaw显著优于传统方法.
- 该框架系统地量化了克隆动态,并确定了驱动器克隆.
- 证明了对瘤异质性的更好理解以及对免疫疗法反应的可解释的见解.
结论:
- TMBclaw提供了一种强大的方法,通过计算瘤克隆异质性来预测免疫治疗反应.
- 该方法有可能改进患者分层,以实现个性化癌症治疗策略.
- 为深入了解瘤进化和癌症患者免疫反应提供了一个框架.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

